CAREER: Protein degradation during the maternal-to-zygotic transition

职业:母体向合子转变过程中的蛋白质降解

基本信息

项目摘要

For all life forms, development is a highly synchronized and fundamental process. The initial stages of animal development are directed by biomolecules that were made by the mother and deposited into the growing egg. Once they have served their role, these maternal biomolecules must be removed and replaced with new ones made by the embryo. This process, known as the maternal-to-zygotic transition, is essential for animal embryogenesis. Despite the importance of the maternal-to-zygotic transition, little attention has been placed on understanding how maternal proteins are removed. The goal of this CAREER award is to fill this gap through a combination of genetic and molecular biology techniques. This research will provide an entry point into three poorly understood, but critical, questions: 1) how do embryos target maternal proteins for degradation; 2) how is protein degradation controlled during development; and 3) what are the developmental consequences when this process goes awry? This award will also provide 15-month paid internships to undergraduates who identify as underrepresented minorities and study at a local undergraduate institution, Metropolitan State University of Denver (Metro). Meaningful research experiences, like the ones provided by this award, will set the students on a trajectory of success in science. This award will thus map the enormous scope of protein removal in driving embryogenesis, will transform the educational ecosystem in Denver, and ultimately will help to increase diversity in science. In Drosophila melanogaster, an E2 ubiquitin-conjugating enzyme known as “Marie Kondo” removes several maternal proteins that were critical for oogenesis but are not needed by the embryo. Marie Kondo works with an E3 ubiquitin ligase called the CTLH complex. However, little is known about how Marie Kondo and the CTLH complex are controlled. Using a combination of genetics and molecular biology, this project will investigate the mechanisms underlying the tight temporal control of substrate specificities and enzymatic activities of Marie Kondo and its partner, the CTLH complex, and determine the developmental consequences of mistiming their activity. Finally, as part of the educational program, an RNAi-based screen will be used to identify other E2s and E3s essential for the Drosophila embryogenesis, which will set the stage for future investigations in maternal protein removal during the maternal-to-zygotic transition. Together, these investigations will shed light on a new area of developmental biology—protein decay—that is critical for the creation of an adult animal from a single-cell embryo.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
对于所有生命形式来说,发展是一个高度同步的基本过程。动物发育的最初阶段是由母亲制造的生物分子引导的,并沉积在成长的卵子中。一旦它们发挥了作用,这些母体生物分子必须被移除,并被胚胎产生的新分子取代。这一过程被称为母体到合子的转变,是动物胚胎发生所必需的。尽管母亲到合子的过渡的重要性,很少有人注意到已经放在了解母亲的蛋白质是如何被删除。这个职业奖的目标是通过遗传和分子生物学技术的结合来填补这一空白。这项研究将为三个知之甚少但至关重要的问题提供一个切入点:1)胚胎如何靶向母体蛋白质降解; 2)在发育过程中如何控制蛋白质降解; 3)当这个过程出错时,发育后果是什么?该奖项还将为那些被认定为代表性不足的少数民族的本科生提供15个月的带薪实习机会,并在当地的本科院校丹佛大都会州立大学(Metro)学习。有意义的研究经验,像这个奖项所提供的,将设置在科学成功的轨道上的学生。因此,该奖项将绘制蛋白质去除在驱动胚胎发生中的巨大范围,将改变丹佛的教育生态系统,并最终将有助于增加科学的多样性。在黑腹果蝇中,一种被称为“玛丽近藤”的E2泛素结合酶去除了几种对卵子发生至关重要但胚胎不需要的母体蛋白。玛丽近藤与E3泛素连接酶称为CTLH复合物。然而,关于近藤玛丽和CTLH复合体是如何控制的,人们知之甚少。使用遗传学和分子生物学相结合,该项目将调查的机制,严格的时间控制的底物特异性和酶活性的玛丽近藤和它的合作伙伴,CTLH复合物,并确定其活动的发展后果的时机不对。最后,作为教育计划的一部分,基于RNAi的筛选将用于鉴定果蝇胚胎发生所必需的其他E2和E3,这将为未来在母体到合子过渡期间母体蛋白去除的研究奠定基础。总之,这些研究将揭示发育生物学的一个新领域--蛋白质衰变--这对于从单细胞胚胎培育成年动物至关重要。该奖项反映了NSF的法定使命,并被认为值得通过使用基金会的智力价值和更广泛的影响审查标准进行评估来支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Olivia Rissland其他文献

Olivia Rissland的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
  • 批准号:
    32372636
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
抑制Protein Kinase D促进胚胎干细胞自我更新的分子机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
C2 DOMAIN PROTEIN 1 (C2DP1)基因家族在植物开花调控中的功能研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
凡纳滨对虾Laccase-like protein非酶活依赖参与抗WSSV免疫的分子机制
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 批准年份:
    2021
  • 资助金额:
    58.00 万元
  • 项目类别:
    面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
玉米基因Dirigent protein 4的克隆和功能鉴定
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
C1q/TNF-related protein 9调控平滑肌细胞程序性坏死抑制动脉粥样硬化的机制研究
  • 批准号:
    81900309
  • 批准年份:
    2019
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Understanding targeted protein degradation for design of optimized therapeutic strategies
了解靶向蛋白质降解以设计优化的治疗策略
  • 批准号:
    BB/X007499/1
  • 财政年份:
    2023
  • 资助金额:
    $ 130万
  • 项目类别:
    Research Grant
Arginyl-tRNA beyond translation: mechanism and regulation of protein arginylation
超越翻译的精氨酰-tRNA:蛋白质精氨酰化的机制和调控
  • 批准号:
    10711167
  • 财政年份:
    2023
  • 资助金额:
    $ 130万
  • 项目类别:
Vascular Smooth Muscle Protein Quality Control and Aortic Aneurysm Formation
血管平滑肌蛋白质量控制与主动脉瘤形成
  • 批准号:
    10714562
  • 财政年份:
    2023
  • 资助金额:
    $ 130万
  • 项目类别:
Tau protein proteolysis signaling in Alzheimer's disease
阿尔茨海默病中的 Tau 蛋白水解信号
  • 批准号:
    10728202
  • 财政年份:
    2023
  • 资助金额:
    $ 130万
  • 项目类别:
Improved optimization of covalent ligands using a novel implementation of quantum mechanics suitable for large ligand/protein systems.
使用适用于大型配体/蛋白质系统的量子力学的新颖实现改进了共价配体的优化。
  • 批准号:
    10601968
  • 财政年份:
    2023
  • 资助金额:
    $ 130万
  • 项目类别:
Understanding GABAA receptor protein folding and misfolding
了解 GABAA 受体蛋白折叠和错误折叠
  • 批准号:
    10744869
  • 财政年份:
    2023
  • 资助金额:
    $ 130万
  • 项目类别:
DynProtect - Mechanisms of dynein-dependent transport and degradation of protein aggregates.
DynProtect - 动力蛋白依赖性运输和蛋白质聚集体降解的机制。
  • 批准号:
    EP/Y026004/1
  • 财政年份:
    2023
  • 资助金额:
    $ 130万
  • 项目类别:
    Fellowship
Temporal coordination of transcription, translation, and protein degradation for meiotic termination
减数分裂终止的转录、翻译和蛋白质降解的时间协调
  • 批准号:
    2319006
  • 财政年份:
    2023
  • 资助金额:
    $ 130万
  • 项目类别:
    Standard Grant
PROTACs as a novel Approach to target Protein Tyrosine Kinases for degradation in human Platelets
PROTAC 作为一种靶向蛋白酪氨酸激酶降解人血小板的新方法
  • 批准号:
    BB/X017176/1
  • 财政年份:
    2023
  • 资助金额:
    $ 130万
  • 项目类别:
    Research Grant
Targeting Menin Protein Stability In AML
靶向 AML 中的 Menin 蛋白稳定性
  • 批准号:
    10644645
  • 财政年份:
    2023
  • 资助金额:
    $ 130万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了